By 2050, the number of worldwide cancer cases and deaths will rise to 35.3 million and 18.5 million, respectively, according to a Nov. 5 study published in JAMA Open Network.
The Latest
CMS released its 2025 Physician Fee Schedule Nov. 1, finalizing a conversion factor of $32.35, down 2.83% from $33.29 in 2024.
A team from Morgantown, W.Va.-based WVU Cancer Institute has become the first in the world to commercially use a new, FDA-approved medical device designed to lower the risk of esophageal cancer.
Houston-based University of Texas MD Anderson Cancer Center has appointed Jennifer Bickel, MD, as the center's first vice president and chief wellness officer.
Newport Beach, Calif.-based Hoag has launched an oncoplastic breast surgery fellowship, the first fellowship of its kind in the U.S.
In September 2023, Boston-based Dana-Farber Cancer Institute rolled out plans to build a freestanding cancer center with Boston-based Beth Israel Deaconess Medical Center, a move that will end the institute's existing oncology partnership with Brigham and Women's Hospital, also in…
As part of its Cancer Moonshot initiative, the Biden administration will launch a private sector pilot program by the end of the year to address pediatric cancer drug shortages.
When Duarte, Calif.-based City of Hope opened its doors in 1913, it did so as a tuberculosis sanatorium. Though more than a century has passed, echoes of the center's past remain at the forefront of the center's mission.
The FDA recently approved the use of blood tests for colon cancer screening, presenting a less invasive option for patients hoping to forgo undergoing a colonoscopy. But according to a study published Oct. 28 in Annals of Internal Medicine, the…
Houston-based University of Texas MD Anderson Cancer Center has appointed Jennifer Finkel, PhD, as associate vice president of art experience to help create a multisensory environment that promotes health and well-being.